A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis
Conditions: Dermatomyositis; Myositis Interventions: Biological: Empasiprubart IV; Other: Placebo IV Sponsors: argenx Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis
Conditions: Atopic Dermatitis Interventions: Drug: Placebo; Drug: Lebrikizumab; Drug: Topical Corticosteroid Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis
Conditions: Atopic Dermatitis Interventions: Biological: CM310; Other: placebo Sponsors: Keymed Biosciences Co.Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.
Conditions: Atopic Dermatitis Interventions: Drug: LNK01001; Drug: Placebo Sponsors: Lynk Pharmaceuticals Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
HIP-STITCH (Wound Recovery After THA)
Conditions: Wound Healing Disturbance of Interventions: Device: Ethicon Monocryl Smooth Suture; Device: Ethicon Vicryl Rapide Braided Suture; Device: Flexifuze Indermil Topical Skin Adhesive; Device: Dermabond Prineo Skin Closure System; Device: Stryker Zip Skin Closure System Sponsors: Reinier Haga Orthopedisch Centrum Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis
Conditions: Psoriasis; Atopic Dermatitis Interventions: Device: CT-100-004-A; Device: CT-100-004-B Sponsors: Click Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms
Conditions: Atopic Dermatitis; Eczema Interventions: Dietary Supplement: Placebo; Dietary Supplement: ACT01; Dietary Supplement: ACT02 Sponsors: Abyss Ingredients; Eurofins Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants
Conditions: Atopic Dermatitis Interventions: Drug: Rocatinlimab vial injection; Combination Product: Rocatinlimab prefilled syringe Sponsors: Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Axis(TM) Solvent-dehydrate Dermal Allograft in the Treatment of Pelvic Organ Prolapse.
Conditions: Pelvic Organ Prolapse Interventions: Device: Axis Dermis biologic mesh repair for pelvic organ prolapse Sponsors: Michigan Institution of Women ' s Health PC; Coloplast A/S Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions
Conditions: Acne; Acne Vulgaris; Alopecia, Androgenetic; Pigmented Lesions; Pigmented Skin Lesion Sponsors: AI Labs Group S.L; Instituto de Dermatolog ía Integral (IDEI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
Conditions: Pregnancy Related; Atopic Dermatitis Interventions: Drug: Ruxolitinib Cream Sponsors: Incyte Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Clinical and Histological Study of a Novel Dermal Substitute
Conditions: Skin Transplantation Interventions: Other: Standard of care Sponsors: University Children ' s Hospital, Zurich; University of Zurich Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Repurposing Ivermectin for PKDL Treatment
Conditions: Post-kala-azar Dermal Leishmaniasis Interventions: Drug: Ivermectin 6 Mg Oral Tablet; Drug: Miltefosine Oral Capsule Sponsors: International Centre for Diarrhoeal Disease Research, Bangladesh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
A Single-stage Bilayered Skin Reconstruction With Glyaderm ®
Conditions: Burns; Full Thickness Burn; Necrotizing Fascitis Interventions: Procedure: Dermal subsitute Glyaderm + skin graft; Procedure: Skin graft alone Sponsors: University Hospital, Ghent; Research Foundation Flanders Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis
Conditions: Dermatitis, Atopic Interventions: Drug: BMS-986326; Other: Placebo Sponsors: Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
